Thompson, AJ; (1996) Clinical review of multiple sclerosis. CLIN IMMUNOTHER , 5 1 - 11.
Full text not available from this repository.
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of unknown cause. It can affect any part of the central nervous system in a variable and unpredictable way. Because it begins in early adult life and has little effect on longevity, it has a major long term impact on family, work and social life. Prompt and accurate diagnosis is essential and has been assisted by the introduction of magnetic resonance imaging, which is also invaluable in monitoring disease activity. Many of the symptoms of MS may now be helped with medical and therapy input, often in combination. Management of MS needs to address the changing needs of this population in a comprehensive and flexible way, and service provision should reflect this approach.
|Title:||Clinical review of multiple sclerosis|
|Keywords:||QUALITY-OF-LIFE, DOUBLE-BLIND, INTRATHECAL BACLOFEN, NATURAL-HISTORY, FOLLOW-UP, DYSFUNCTION, POPULATION, SPASTICITY, 4-AMINOPYRIDINE, PREVALENCE|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Brain Sciences|
Archive Staff Only: edit this record